Professor Derek Rosario: key facts
- Kind of voice
- Clinician
- Role
- consultant urological surgeon and clinical advisor to the UK NSC
- Quoted on
- Cancer
- Press citations held
- 2
- Most recently quoted
- 10 Sept 2026
“This is clear evidence of benefit, but perhaps not as much as we might have anticipated. It is important to note that alongside this, there was no discernible difference in the overall all-cause mortality, i.e, approximately 50% of men died in each arm, whether screened or not.”
What Professor Derek Rosario has said
“The importance of optimising quality of life for men with prostate cancer cannot be overstated. As well as the direct individual benefit, we know that optimising quality of life and mitigating fatigue through exercise has potential beneficial effects on overall survival.”
Chief investigator of STAMINA and consultant urological surgeon at Sheffield Teaching Hospitals NHS Trust · Cancer · 10 Sept 2026 · Supervised exercise programme shows benefit for prostate cancer in NHS trial ↗
Where Professor Derek Rosario has been quoted
- PSA screening may prevent more deaths than previously thought, study findspulsetoday.co.uk · 10 Sept 2026
- Supervised exercise programme shows benefit for prostate cancer in NHS trialpulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.